¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-11
±³À°ÀÏÀÚ : 2024-05-11
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï

±³À°ÁÖÁ¦ : 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ
´ã´çÀÚ : Á¤ÃáÈñ
¿¬¶ôó : 02-747-0528  

À̸ÞÀÏ : kaaaci@naver.com

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, °¡Á¤ÀÇÇаú

Âü¼®¿¹»óÀÎ : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 18 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 140,000¿ø  

ºñ°í »çÀüµî·Ï: Àü¹®ÀÇ, ÀϹÝÀÇ, ±³¼ö 10¸¸¿ø, Àü°øÀÇ, ±âŸ 5¸¸¿ø / ´çÀϵî·Ï: Àü¹®ÀÇ, ÀϹÝÀÇ, ±³¼ö 14¸¸¿ø, Àü°øÀÇ, ±âŸ 7¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 09:00~10:00 Treatable Trait in Asthma Peter Gibson(Monash University, Austrailia)

ÈÞ½Ä 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï 10:00~10:20 ÈÞ½Ä ()

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 10:20~10:50 Novel Mechanisms of Immunotherapy: The Role of EAACI Research and Outreach Biobank Project Milena Sokolowska(University of Zurich, Switzerland)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 10:50~11:20 SCIT in Real Life Asli Gelincik(Istanbul University, Turkey )

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 11:20~11:50 Novel immunotherapy strategies enhancing treatment outcomes ÀÌ»ó¹Î(´Ü±¹ÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëB 10:20~10:50 The role of eosinophils in airway diseases: asthma and beyond ±èÁÖÈñ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëB 10:50~11:20 Biomarkers of eosinophil activation ±èÈ¿ºó(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëB 11:20~11:50 Updates in mechanism of hypereosinophilic syndrome °­³ëÀ»(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëC 10:20~10:50 The latest trends in molecular target research for drug development ¹Ú»ó±Ô(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëC 10:50~11:20 Innovation in clinical trials: New strategies for asthma and allergy drug development ¹ÝÁØ¿ì(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëC 11:20~11:50 Regulatory science and drug approval process: Overcoming challenges through global collaboration ½ÅÁÖ¿µ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëD 10:20~10:50 Emerging insights into innate immunity in allergic airway inflammation Á¶ÇüÁÖ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëD 10:50~11:20 Comorbidities of allergic rhinitis (sleep apnea, adenoid hypertrophy, AERD, etc) ±èµ¿±Ô(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëD 11:20~11:50 Personalized medicine of rhinosinusitis : from current biologics to unmet needs Mitsuhiro Okano(International University of Health and Welfare, Japan)

ÈÞ½Ä 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï 11:50~12:00 ÈÞ½Ä ()

±âŸ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 12:00~12:50 The Evolution of Chronic Urticaria Care: Emerging Trends and Insights Emek Kocaturk(Koç University, Turkey)

±âŸ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëB 12:00~12:50 Asthma John Blakey(Curtin Medical School, Australia)

±âŸ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëC 12:00~12:50 Immunotherapy Johann Virchow(University Hospital Rostock, Germany)

ÈÞ½Ä 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï 12:50~13:30 ÈÞ½Ä ()

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 13:30~14:30 Angioedema from Bench to Bedside: An Update on the EAACI Knowledge Hub Module Asli Gelincik(Istanbul University, Turkey )

ÈÞ½Ä 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï 14:30~14:50 ÈÞ½Ä ()

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 14:50~15:20 Asthma Management and Environmental Impact Hiromasa Inoue(Kagoshima University, Japan)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 15:20~15:50 Air pollution and asthma ±ÇÇõ¼ö(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 15:50~16:20 How to mitigate the adverse effects of air pollution on respiratory allergic diseases ¼Û´ëÁø(°í·ÁÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëB 14:50~16:20 Intestinal permeability and its correlation with treatable traits and inflammatory markers in severe asthma: the Korean Severe Asthma Registry (KoSAR) data analysis ¹ÚÇÑ±â ¿Ü 9¸í(°æºÏÀÇ´ë ¿Ü 9°÷)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëC 14:50~16:20 A 10-year Longitudinal Analysis of Adult Asthmatics with Obesity Unveils Dual Eosinophilic and Neutrophilic Inflammation ÀüÇö¼· ¿Ü 9¸í(¾ÆÁÖÀÇ´ë ¿Ü 9°÷)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëD 14:50~16:20 Targeted inhibition of m6A demethylase FTO by FB23 attenuates allergic inflammation in the airway epithelium Zexuan Lian ¿Ü 9¸í(Guangzhou Medical University ¿Ü 9°÷)

ÈÞ½Ä 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï 16:20~16:30 ÈÞ½Ä ()

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 16:30~17:00 Upper airway disease: AR/CRS ³ª¹Î¼®(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 17:00~17:30 Lower airway disease: Asthma ¹Ý°¡¿µ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëA 17:30~18:00 Allergic skin disease: AD/CU Á¤°æ¿í(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëB 16:30~17:15 Asthma remission during biologics treatment ½É´Ù¿î/¿ì¼º´ë(Àü³²ÀÇ´ë/Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëB 17:15~18:00 Early dietary interventions for food allergy in children Á¤¹Î¿µ/À±Áö¼±(°í½ÅÀÇ´ë/Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëC 16:30~17:00 Small airway dysfunction in asthma and COPD Omar Usmani(Imperial College London, UK)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëC 17:00~17:30 Unravelling lung function decline in adults with or without asthma ¹ÚÈï¿ì(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 05¿ù 11ÀÏ ±×·£µå ¿öÄ¿Èú ¼­¿ï ·ëC 17:30~18:00 Recent findings from COPD cohort studies: Focusing on Korean research ¹®Áö¿ë(ÇѾçÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀü¸³¼±ÇÐȸ The 3rd Korean Prostate Society Prostate Cancer Working Group Symposium : 2024-05-11
´ÙÀ½±Û Á¦77Â÷ ´ëÇÑû°¢ÇÐȸ Çмú´ëȸ : 2024-05-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20835 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ 2024³â Á¦ 1ȸ ³»½Ã°æ Áý´ãȸ : 2024-06-21 0 31 2024-05-27
20834 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¾È°ú ±Ý¿äÁý´ãȸ : 2024-06-21 0 8 2024-05-27
20833 ¼­¿ï ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 1ÀÏÂ÷ : 2024-06-21 0 18 2024-05-27
20832 ¼­¿ï Á¦8Â÷ µµºÀ±¸ÀÇ»çȸ Çмú¼¼¹Ì³ª(½ÉÇ÷°üÁúȯ ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á, ºÒ¸éÁõ, Ä¡¸Å¾à¹°Ä¡·á, Ç×Ç÷ÀüÁ¦) : 2024-06-21 0 13 2024-05-27
20831 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (2ÀÏÂ÷) : 2024-06-21 0 4 2024-05-27
20830 Á¦ÁÖ ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-21 0 8 2024-05-27
20829 ¼­¿ï 2024³â °áÇÙ°ü¸®±³À° 2±â(1ÀÏÂ÷) : 2024-06-20 0 5 2024-05-27
20828 ºÎ»ê ´ëÇѼҾÆû¼Ò³â°úÇÐȸ ºÎ»êÁöȸ Áý´ãȸ : 2024-06-20 0 15 2024-05-27
20827 ºÎ»ê ´ëÇѾȰúÇÐȸ ºÎ»êÁöȸ Á¦ 510ȸ ÇмúÁý´ãȸ : 2024-06-20 0 9 2024-05-27
20826 ºÎ»ê 2024³âµµ ºÎ»ê․°æ³²Áö¿ª ÀÇ°ú´ëÇÐ ½ÅÀÓ±³¼ö ¿öÅ©¼ó (1ÀÏÂ÷) : 2024-06-20 0 6 2024-05-27
20825 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÅëÁõÇÐȸ ¼­¿ïÁöȸ Áý´ãȸ : 2024-06-20 0 7 2024-05-27
20824 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À°(¼­½Ä ÀÛ¼º ½ÇÁ¦) : 2024-06-20 0 7 2024-05-27
20823 °æ±â µ¿±¹´ëÇб³ Àϻ꺴¿ø : °ñ°üÀý¿°ÀÇ Áø´Ü ¹× Ä¡·á : 2024-06-19 0 9 2024-05-27
20822 °æ±â ´ëÇÑ°£ÇÐȸ Overlooked Liver Diseases : 2024-06-19 0 16 2024-05-27
20821 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦2ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-06-17 0 30 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷